{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T16:44:55Z","timestamp":1794674695039,"version":"4.9.1"},"reference-count":197,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T00:00:00Z","timestamp":1704153600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T00:00:00Z","timestamp":1704153600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Cardiol"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1038\/s41569-023-00957-0","type":"journal-article","created":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T20:02:12Z","timestamp":1704139332000},"page":"312-325","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":221,"title":["Programmed death of macrophages in atherosclerosis: mechanisms and therapeutic targets"],"prefix":"10.1038","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3848-8702","authenticated-orcid":false,"given":"Guido R. Y.","family":"De Meyer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0564-1168","authenticated-orcid":false,"given":"Michelle","family":"Zurek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0316-2916","authenticated-orcid":false,"given":"Pauline","family":"Puylaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1967-9343","authenticated-orcid":false,"given":"Wim","family":"Martinet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,2]]},"reference":[{"key":"957_CR1","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/35025203","volume":"407","author":"AJ Lusis","year":"2000","unstructured":"Lusis, A. J. Atherosclerosis. Nature 407, 233\u2013241 (2000).","journal-title":"Nature"},{"key":"957_CR2","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/S0008-6363(99)00235-7","volume":"45","author":"MM Kockx","year":"2000","unstructured":"Kockx, M. M. & Herman, A. G. Apoptosis in atherosclerosis: beneficial or detrimental? Cardiovasc. Res. 45, 736\u2013746 (2000).","journal-title":"Cardiovasc. Res."},{"key":"957_CR3","doi-asserted-by":"crossref","unstructured":"Virmani, R. et al. in The Vulnerable Atherosclerotic Plaque: Strategies for Diagnosis and Management (eds. Virmani, R., Narula, J., Leon, M. & Willerson, J.) 21\u201336 (Blackwell Futura, 2007).","DOI":"10.1002\/9780470987575"},{"key":"957_CR4","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1111\/j.1582-4934.2010.01121.x","volume":"14","author":"HM Wilson","year":"2010","unstructured":"Wilson, H. M. Macrophages heterogeneity in atherosclerosis \u2014 implications for therapy. J. Cell Mol. Med. 14, 2055\u20132065 (2010).","journal-title":"J. Cell Mol. Med."},{"key":"957_CR5","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.cardiores.2006.09.005","volume":"73","author":"DM Schrijvers","year":"2007","unstructured":"Schrijvers, D. M., De Meyer, G. R., Herman, A. G. & Martinet, W. Phagocytosis in atherosclerosis: molecular mechanisms and implications for plaque progression and stability. Cardiovasc. Res. 73, 470\u2013480 (2007).","journal-title":"Cardiovasc. Res."},{"key":"957_CR6","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1097\/00041433-200110000-00009","volume":"12","author":"W Martinet","year":"2001","unstructured":"Martinet, W. & Kockx, M. M. Apoptosis in atherosclerosis: focus on oxidized lipids and inflammation. Curr. Opin. Lipidol. 12, 535\u2013541 (2001).","journal-title":"Curr. Opin. Lipidol."},{"key":"957_CR7","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1161\/ATVBAHA.122.318177","volume":"42","author":"P Puylaert","year":"2022","unstructured":"Puylaert, P., Zurek, M., Rayner, K. J., De Meyer, G. R. Y. & Martinet, W. Regulated necrosis in atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 42, 1283\u20131306 (2022).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"957_CR8","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/s41580-020-0270-8","volume":"21","author":"S Bedoui","year":"2020","unstructured":"Bedoui, S., Herold, M. J. & Strasser, A. Emerging connectivity of programmed cell death pathways and its physiological implications. Nat. Rev. Mol. Cell Biol. 21, 678\u2013695 (2020).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"957_CR9","doi-asserted-by":"publisher","first-page":"845942","DOI":"10.3389\/fcvm.2022.845942","volume":"9","author":"Y Gui","year":"2022","unstructured":"Gui, Y., Zheng, H. & Cao, R. Y. Foam cells in atherosclerosis: novel insights into its origins, consequences, and molecular mechanisms. Front. Cardiovasc. Med. 9, 845942 (2022).","journal-title":"Front. Cardiovasc. Med."},{"key":"957_CR10","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/s41580-020-0232-1","volume":"21","author":"E Boada-Romero","year":"2020","unstructured":"Boada-Romero, E., Martinez, J., Heckmann, B. L. & Green, D. R. The clearance of dead cells by efferocytosis. Nat. Rev. Mol. Cell Biol. 21, 398\u2013414 (2020).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"957_CR11","doi-asserted-by":"publisher","first-page":"1118449","DOI":"10.3389\/fimmu.2023.1118449","volume":"14","author":"Z Xiao","year":"2023","unstructured":"Xiao, Z. et al. Programmed cell death and lipid metabolism of macrophages in NAFLD. Front. Immunol. 14, 1118449 (2023).","journal-title":"Front. Immunol."},{"key":"957_CR12","doi-asserted-by":"publisher","first-page":"S382","DOI":"10.1194\/jlr.R800032-JLR200","volume":"50","author":"T Seimon","year":"2009","unstructured":"Seimon, T. & Tabas, I. Mechanisms and consequences of macrophage apoptosis in atherosclerosis. J. Lipid Res. 50, S382\u2013S387 (2009).","journal-title":"J. Lipid Res."},{"key":"957_CR13","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1161\/hh0801.089261","volume":"88","author":"BJ van Vlijmen","year":"2001","unstructured":"van Vlijmen, B. J. et al. Macrophage p53 deficiency leads to enhanced atherosclerosis in APOE*3-Leiden transgenic mice. Circ. Res. 88, 780\u2013786 (2001).","journal-title":"Circ. Res."},{"key":"957_CR14","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1161\/01.ATV.0000148548.47755.22","volume":"25","author":"J Liu","year":"2005","unstructured":"Liu, J. et al. Reduced macrophage apoptosis is associated with accelerated atherosclerosis in low-density lipoprotein receptor-null mice. Arterioscler. Thromb. Vasc. Biol. 25, 174\u2013179 (2005).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"957_CR15","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.cmet.2005.02.002","volume":"1","author":"S Arai","year":"2005","unstructured":"Arai, S. et al. A role for the apoptosis inhibitory factor AIM\/Sp\u03b1\/Api6 in atherosclerosis development. Cell Metab. 1, 201\u2013213 (2005).","journal-title":"Cell Metab."},{"key":"957_CR16","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1161\/ATVBAHA.115.306931","volume":"36","author":"VR Babaev","year":"2016","unstructured":"Babaev, V. R. et al. Macrophage IKK\u03b1 deficiency suppresses akt phosphorylation, reduces cell survival, and decreases early atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 36, 598\u2013607 (2016).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"957_CR17","doi-asserted-by":"publisher","first-page":"e75","DOI":"10.1161\/ATVBAHA.117.309229","volume":"37","author":"KJ Rayner","year":"2017","unstructured":"Rayner, K. J. Cell death in the vessel wall: the good, the bad, the ugly. Arterioscler. Thromb. Vasc. Biol. 37, e75\u2013e81 (2017).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"957_CR18","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1161\/01.ATV.0000166517.18801.a7","volume":"25","author":"DM Schrijvers","year":"2005","unstructured":"Schrijvers, D. M., De Meyer, G. R., Kockx, M. M., Herman, A. G. & Martinet, W. Phagocytosis of apoptotic cells by macrophages is impaired in atherosclerosis. Arteroscler. Thromb. Vasc. Biol. 25, 1256\u20131261 (2005).","journal-title":"Arteroscler. Thromb. Vasc. Biol."},{"key":"957_CR19","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.atherosclerosis.2021.02.021","volume":"322","author":"I Coornaert","year":"2021","unstructured":"Coornaert, I. et al. Impact of myeloid RIPK1 gene deletion on atherogenesis in ApoE-deficient mice. Atherosclerosis 322, 51\u201360 (2021).","journal-title":"Atherosclerosis"},{"key":"957_CR20","doi-asserted-by":"publisher","first-page":"86","DOI":"10.3389\/fcvm.2017.00086","volume":"4","author":"A Yurdagul Jr","year":"2018","unstructured":"Yurdagul, A. Jr, Doran, A. C., Cai, B., Fredman, G. & Tabas, I. A. Mechanisms and consequences of defective efferocytosis in atherosclerosis. Front. Cardiovasc. Med. 4, 86 (2018).","journal-title":"Front. Cardiovasc. Med."},{"key":"957_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09397-2","volume":"10","author":"C Rogers","year":"2019","unstructured":"Rogers, C. et al. Gasdermin pores permeabilize mitochondria to augment caspase-3 activation during apoptosis and inflammasome activation. Nat. Commun. 10, 1689 (2019).","journal-title":"Nat. Commun."},{"key":"957_CR22","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1007\/s00395-011-0192-x","volume":"106","author":"W Martinet","year":"2011","unstructured":"Martinet, W., Schrijvers, D. M. & De Meyer, G. R. Necrotic cell death in atherosclerosis. Basic Res. Cardiol. 106, 749\u2013760 (2011).","journal-title":"Basic Res. Cardiol."},{"key":"957_CR23","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1161\/01.CIR.99.3.348","volume":"99","author":"Z Mallat","year":"1999","unstructured":"Mallat, Z. et al. Shed membrane microparticles with procoagulant potential in human atherosclerotic plaques: a role for apoptosis in plaque thrombogenicity. Circulation 99, 348\u2013353 (1999).","journal-title":"Circulation"},{"key":"957_CR24","doi-asserted-by":"publisher","first-page":"6707","DOI":"10.1074\/jbc.M510579200","volume":"281","author":"Y Li","year":"2006","unstructured":"Li, Y. et al. Cholesterol-induced apoptotic macrophages elicit an inflammatory response in phagocytes, which is partially attenuated by the Mer receptor. J. Biol. Chem. 281, 6707\u20136717 (2006).","journal-title":"J. Biol. Chem."},{"key":"957_CR25","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1161\/ATVBAHA.108.167197","volume":"28","author":"E Thorp","year":"2008","unstructured":"Thorp, E., Cui, D., Schrijvers, D. M., Kuriakose, G. & Tabas, I. Mertk receptor mutation reduces efferocytosis efficiency and promotes apoptotic cell accumulation and plaque necrosis in atherosclerotic lesions of apoe-\/- mice. Arterioscler. Thromb. Vasc. Biol. 28, 1421\u20131428 (2008).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"957_CR26","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1161\/ATVBAHA.108.169078","volume":"28","author":"H Ait-Oufella","year":"2008","unstructured":"Ait-Oufella, H. et al. Defective mer receptor tyrosine kinase signaling in bone marrow cells promotes apoptotic cell accumulation and accelerates atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 28, 1429\u20131431 (2008).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"957_CR27","doi-asserted-by":"publisher","first-page":"e35","DOI":"10.1161\/CIRCRESAHA.118.313283","volume":"123","author":"W Wang","year":"2018","unstructured":"Wang, W. et al. Macrophage inflammation, erythrophagocytosis, and accelerated atherosclerosis in Jak2 (V617F) mice. Circ. Res. 123, e35\u2013e47 (2018).","journal-title":"Circ. Res."},{"key":"957_CR28","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/nature18935","volume":"536","author":"Y Kojima","year":"2016","unstructured":"Kojima, Y. et al. CD47-blocking antibodies restore phagocytosis and prevent atherosclerosis. Nature 536, 86\u201390 (2016).","journal-title":"Nature"},{"key":"957_CR29","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1091\/mbc.e03-09-0668","volume":"15","author":"G Brouckaert","year":"2004","unstructured":"Brouckaert, G. et al. Phagocytosis of necrotic cells by macrophages is phosphatidylserine dependent and does not induce inflammatory cytokine production. Mol. Biol. Cell 15, 1089\u20131100 (2004).","journal-title":"Mol. Biol. Cell"},{"key":"957_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-019-0437-0","volume":"17","author":"I Shlomovitz","year":"2019","unstructured":"Shlomovitz, I., Speir, M. & Gerlic, M. Flipping the dogma - phosphatidylserine in non-apoptotic cell death. Cell Commun. Signal. 17, 139 (2019).","journal-title":"Cell Commun. Signal."},{"key":"957_CR31","doi-asserted-by":"publisher","DOI":"10.1097\/IN9.0000000000000017","volume":"5","author":"D Kumar","year":"2023","unstructured":"Kumar, D., Pandit, R. & Yurdagul, A. Jr. Mechanisms of continual efferocytosis by macrophages and its role in mitigating atherosclerosis. Immunometabolism 5, e00017 (2023).","journal-title":"Immunometabolism"},{"key":"957_CR32","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.cmet.2020.01.001","volume":"31","author":"A Yurdagul Jr","year":"2020","unstructured":"Yurdagul, A. Jr et al. Macrophage metabolism of apoptotic cell-derived arginine promotes continual efferocytosis and resolution of injury. Cell Metab. 31, 518\u2013533.e10 (2020).","journal-title":"Cell Metab."},{"key":"957_CR33","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1161\/CIRCRESAHA.121.319822","volume":"130","author":"AC Doran","year":"2022","unstructured":"Doran, A. C. Inflammation resolution: implications for atherosclerosis. Circ. Res. 130, 130\u2013148 (2022).","journal-title":"Circ. Res."},{"key":"957_CR34","first-page":"3","volume":"146","author":"G Majno","year":"1995","unstructured":"Majno, G. & Joris, I. Apoptosis, oncosis, and necrosis. An overview of Cell death. Am. J. Pathol. 146, 3\u201315 (1995).","journal-title":"Am. J. Pathol."},{"key":"957_CR35","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S0021-9150(96)06037-6","volume":"130","author":"M Crisby","year":"1997","unstructured":"Crisby, M. et al. Cell death in human atherosclerotic plaques involves both oncosis and apoptosis. Atherosclerosis 130, 17\u201327 (1997).","journal-title":"Atherosclerosis"},{"key":"957_CR36","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1161\/01.ATV.0000184783.04864.9f","volume":"25","author":"I Tabas","year":"2005","unstructured":"Tabas, I. Consequences and therapeutic implications of macrophage apoptosis in atherosclerosis: the importance of lesion stage and phagocytic efficiency. Aterioscler. Thromb. Vasc. Biol. 25, 2255\u20132264 (2005).","journal-title":"Aterioscler. Thromb. Vasc. Biol."},{"key":"957_CR37","doi-asserted-by":"publisher","first-page":"2320","DOI":"10.1161\/01.ATV.0000145573.36113.8a","volume":"24","author":"N Kalinina","year":"2004","unstructured":"Kalinina, N. et al. Increased expression of the DNA-binding cytokine HMGB1 in human atherosclerotic lesions: role of activated macrophages and cytokines. Arterioscler. Thromb. Vasc. Biol. 24, 2320\u20132325 (2004).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"957_CR38","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/j.autrev.2012.03.007","volume":"11","author":"AW de Souza","year":"2012","unstructured":"de Souza, A. W., Westra, J., Limburg, P. C., Bijl, M. & Kallenberg, C. G. HMGB1 in vascular diseases: its role in vascular inflammation and atherosclerosis. Autoimmun. Rev. 11, 909\u2013917 (2012).","journal-title":"Autoimmun. Rev."},{"key":"957_CR39","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1161\/ATVBAHA.110.218669","volume":"31","author":"P Kanellakis","year":"2011","unstructured":"Kanellakis, P. et al. High-mobility group box protein 1 neutralization reduces development of diet-induced atherosclerosis in apolipoprotein e-deficient mice. Arterioscler. Thromb. Vasc. Biol. 31, 313\u2013319 (2011).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"957_CR40","doi-asserted-by":"publisher","first-page":"2716","DOI":"10.1161\/01.ATV.0000249630.02085.12","volume":"26","author":"C Cuccurullo","year":"2006","unstructured":"Cuccurullo, C. et al. Suppression of RAGE as a basis of simvastatin-dependent plaque stabilization in type 2 diabetes. Arterioscler. Thromb. Vasc. Biol. 26, 2716\u20132723 (2006).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"957_CR41","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1007\/s00125-008-1060-6","volume":"51","author":"AC Calkin","year":"2008","unstructured":"Calkin, A. C. et al. The HMG-CoA reductase inhibitor rosuvastatin and the angiotensin receptor antagonist candesartan attenuate atherosclerosis in an apolipoprotein E-deficient mouse model of diabetes via effects on advanced glycation, oxidative stress and inflammation. Diabetologia 51, 1731\u20131740 (2008).","journal-title":"Diabetologia"},{"key":"957_CR42","first-page":"306","volume":"22","author":"YX Yin","year":"2010","unstructured":"Yin, Y. X. et al. The effect of simvastatin on the expression of high mobility group box-1 protein in atherosclerotic rats [Chinese]. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 22, 306\u2013308 (2010).","journal-title":"Zhongguo Wei Zhong Bing Ji Jiu Yi Xue"},{"key":"957_CR43","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1038\/aps.2013.8","volume":"34","author":"M Liu","year":"2013","unstructured":"Liu, M. et al. Simvastatin suppresses vascular inflammation and atherosclerosis in ApoE\u2212\/\u2212 mice by downregulating the HMGB1-RAGE axis. Acta Pharmacol. Sin. 34, 830\u2013836 (2013).","journal-title":"Acta Pharmacol. Sin."},{"key":"957_CR44","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.freeradbiomed.2021.05.009","volume":"171","author":"Y Zhou","year":"2021","unstructured":"Zhou, Y. et al. Verification of ferroptosis and pyroptosis and identification of PTGS2 as the hub gene in human coronary artery atherosclerosis. Free Radic. Biol. Med. 171, 55\u201368 (2021).","journal-title":"Free Radic. Biol. Med."},{"key":"957_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-06762-y","volume":"12","author":"E Uyy","year":"2022","unstructured":"Uyy, E. et al. Regulated cell death joins in atherosclerotic plaque silent progression. Sci. Rep. 12, 2814 (2022).","journal-title":"Sci. Rep."},{"key":"957_CR46","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/nchembio711","volume":"1","author":"A Degterev","year":"2005","unstructured":"Degterev, A. et al. Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury. Nat. Chem. Biol. 1, 112\u2013119 (2005).","journal-title":"Nat. Chem. Biol."},{"key":"957_CR47","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/nchembio.83","volume":"4","author":"A Degterev","year":"2008","unstructured":"Degterev, A. et al. Identification of RIP1 kinase as a specific cellular target of necrostatins. Nat. Chem. Biol. 4, 313\u2013321 (2008).","journal-title":"Nat. Chem. Biol."},{"key":"957_CR48","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1016\/j.cell.2009.05.037","volume":"137","author":"YS Cho","year":"2009","unstructured":"Cho, Y. S. et al. Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation. Cell 137, 1112\u20131123 (2009).","journal-title":"Cell"},{"key":"957_CR49","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1016\/j.cell.2009.05.021","volume":"137","author":"S He","year":"2009","unstructured":"He, S. et al. Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-\u03b1. Cell 137, 1100\u20131111 (2009).","journal-title":"Cell"},{"key":"957_CR50","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1126\/science.1172308","volume":"325","author":"DW Zhang","year":"2009","unstructured":"Zhang, D. W. et al. RIP3, an energy metabolism regulator that switches TNF-induced cell death from apoptosis to necrosis. Science 325, 332\u2013336 (2009).","journal-title":"Science"},{"key":"957_CR51","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.celrep.2014.04.026","volume":"7","author":"Y Dondelinger","year":"2014","unstructured":"Dondelinger, Y. et al. MLKL compromises plasma membrane integrity by binding to phosphatidylinositol phosphates. Cell Rep. 7, 971\u2013981 (2014).","journal-title":"Cell Rep."},{"key":"957_CR52","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.molcel.2014.03.003","volume":"54","author":"H Wang","year":"2014","unstructured":"Wang, H. et al. Mixed lineage kinase domain-like protein MLKL causes necrotic membrane disruption upon phosphorylation by RIP3. Mol. Cell 54, 133\u2013146 (2014).","journal-title":"Mol. Cell"},{"key":"957_CR53","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/nrm3737","volume":"15","author":"T Vanden Berghe","year":"2014","unstructured":"Vanden Berghe, T., Linkermann, A., Jouan-Lanhouet, S., Walczak, H. & Vandenabeele, P. Regulated necrosis: the expanding network of non-apoptotic cell death pathways. Nat. Rev. Mol. Cell Biol. 15, 135\u2013147 (2014).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"957_CR54","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.1600224","volume":"2","author":"D Karunakaran","year":"2016","unstructured":"Karunakaran, D. et al. Targeting macrophage necroptosis for therapeutic and diagnostic interventions in atherosclerosis. Sci. Adv. 2, e1600224 (2016).","journal-title":"Sci. Adv."},{"key":"957_CR55","doi-asserted-by":"publisher","DOI":"10.1038\/srep21992","volume":"6","author":"F Tian","year":"2016","unstructured":"Tian, F. et al. 5-Aminolevulinic acid-mediated sonodynamic therapy inhibits RIPK1\/RIPK3-dependent necroptosis in THP-1-derived foam cells. Sci. Rep. 6, 21992 (2016).","journal-title":"Sci. Rep."},{"key":"957_CR56","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1161\/ATVBAHA.119.313290","volume":"40","author":"E Karshovska","year":"2020","unstructured":"Karshovska, E. et al. HIF-1\u03b1 (hypoxia-inducible factor-1\u03b1) promotes macrophage necroptosis by regulating miR-210 and miR-383. Arterioscler. Thromb. Vasc. Biol. 40, 583\u2013596 (2020).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"957_CR57","doi-asserted-by":"publisher","first-page":"809516","DOI":"10.3389\/fcell.2021.809516","volume":"9","author":"C Liu","year":"2021","unstructured":"Liu, C., Jiang, Z., Pan, Z. & Yang, L. The function, regulation and mechanism of programmed cell death of macrophages in atherosclerosis. Front. Cell Dev. Biol. 9, 809516 (2021).","journal-title":"Front. Cell Dev. Biol."},{"key":"957_CR58","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.cca.2017.11.005","volume":"476","author":"YJ Xu","year":"2018","unstructured":"Xu, Y. J., Zheng, L., Hu, Y. W. & Wang, Q. Pyroptosis and its relationship to atherosclerosis. Clin. Chim. Acta 476, 28\u201337 (2018).","journal-title":"Clin. Chim. Acta"},{"key":"957_CR59","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.tibs.2016.10.004","volume":"42","author":"J Shi","year":"2017","unstructured":"Shi, J., Gao, W. & Shao, F. Pyroptosis: gasdermin-mediated programmed necrotic cell death. Trends Biochem. Sci. 42, 245\u2013254 (2017).","journal-title":"Trends Biochem. Sci."},{"key":"957_CR60","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s10565-019-09496-2","volume":"36","author":"JG Nirmala","year":"2020","unstructured":"Nirmala, J. G. & Lopus, M. Cell death mechanisms in eukaryotes. Cell Biol. Toxicol. 36, 145\u2013164 (2020).","journal-title":"Cell Biol. Toxicol."},{"key":"957_CR61","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1016\/j.jstrokecerebrovasdis.2015.03.024","volume":"24","author":"X Shi","year":"2015","unstructured":"Shi, X., Xie, W. L., Kong, W. W., Chen, D. & Qu, P. Expression of the NLRP3 inflammasome in carotid atherosclerosis. J. Stroke Cerebrovasc. Dis. 24, 2455\u20132466 (2015).","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"957_CR62","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1161\/ATVBAHA.115.307312","volume":"36","author":"K Rajamaki","year":"2016","unstructured":"Rajamaki, K. et al. p38\u03b4 MAPK: a novel regulator of NLRP3 inflammasome activation with increased expression in coronary atherogenesis. Arterioscler. Thromb. Vasc. Biol. 36, 1937\u20131946 (2016).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"957_CR63","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.115.003031","volume":"5","author":"G Paramel Varghese","year":"2016","unstructured":"Paramel Varghese, G. et al. NLRP3 inflammasome expression and activation in human atherosclerosis. J. Am. Heart Assoc. 5, e003031 (2016).","journal-title":"J. Am. Heart Assoc."},{"key":"957_CR64","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0011765","volume":"5","author":"K Rajam\u00e4ki","year":"2010","unstructured":"Rajam\u00e4ki, K. et al. Cholesterol crystals activate the NLRP3 inflammasome in human macrophages: a novel link between cholesterol metabolism and inflammation. PLoS ONE\u00a05, e11765 (2010).","journal-title":"PLoS ONE"},{"key":"957_CR65","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1038\/nature08938","volume":"464","author":"P Duewell","year":"2010","unstructured":"Duewell, P. et al. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature 464, 1357\u20131361 (2010).","journal-title":"Nature"},{"key":"957_CR66","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1194\/jlr.S091280","volume":"60","author":"AR Tall","year":"2019","unstructured":"Tall, A. R. & Westerterp, M. Inflammasomes, neutrophil extracellular traps, and cholesterol. J. Lipid Res. 60, 721\u2013727 (2019).","journal-title":"J. Lipid Res."},{"key":"957_CR67","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1093\/cvr\/cvac189","volume":"119","author":"M Yalcinkaya","year":"2023","unstructured":"Yalcinkaya, M. et al. Cholesterol accumulation in macrophages drives NETosis in atherosclerotic plaques via IL-1\u03b2 secretion. Cardiovasc. Res. 119, 969\u2013981 (2023).","journal-title":"Cardiovasc. Res."},{"key":"957_CR68","doi-asserted-by":"publisher","first-page":"657486","DOI":"10.3389\/fphar.2021.657486","volume":"12","author":"M Jiang","year":"2021","unstructured":"Jiang, M. et al. Caspase-11-gasdermin D-mediated pyroptosis is involved in the pathogenesis of atherosclerosis. Front. Pharmacol. 12, 657486 (2021).","journal-title":"Front. Pharmacol."},{"key":"957_CR69","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1248\/bpb.b12-00571","volume":"36","author":"SJ Son","year":"2013","unstructured":"Son, S. J. et al. Triglyceride-induced macrophage cell death is triggered by caspase-1. Biol. Pharm. Bull. 36, 108\u2013113 (2013).","journal-title":"Biol. Pharm. Bull."},{"key":"957_CR70","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1016\/j.hlc.2013.01.012","volume":"22","author":"F Zheng","year":"2013","unstructured":"Zheng, F., Xing, S., Gong, Z. & Xing, Q. NLRP3 inflammasomes show high expression in aorta of patients with atherosclerosis. Heart Lung Circ. 22, 746\u2013750 (2013).","journal-title":"Heart Lung Circ."},{"key":"957_CR71","doi-asserted-by":"publisher","first-page":"507208","DOI":"10.1155\/2014\/507208","volume":"2014","author":"F Zheng","year":"2014","unstructured":"Zheng, F., Xing, S., Gong, Z., Mu, W. & Xing, Q. Silence of NLRP3 suppresses atherosclerosis and stabilizes plaques in apolipoprotein E-deficient mice. Mediators Inflamm. 2014, 507208 (2014).","journal-title":"Mediators Inflamm."},{"key":"957_CR72","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-98437-3","volume":"11","author":"W Zeng","year":"2021","unstructured":"Zeng, W. et al. The selective NLRP3 inhibitor MCC950 hinders atherosclerosis development by attenuating inflammation and pyroptosis in macrophages. Sci. Rep. 11, 19305 (2021).","journal-title":"Sci. Rep."},{"key":"957_CR73","doi-asserted-by":"publisher","first-page":"772","DOI":"10.2337\/db20-0357","volume":"70","author":"A Sharma","year":"2021","unstructured":"Sharma, A. et al. Specific NLRP3 inhibition protects against diabetes-associated atherosclerosis. Diabetes 70, 772\u2013787 (2021).","journal-title":"Diabetes"},{"key":"957_CR74","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1161\/ATVBAHA.117.309575","volume":"37","author":"T van der Heijden","year":"2017","unstructured":"van der Heijden, T. et al. NLRP3 inflammasome inhibition by MCC950 reduces atherosclerotic lesion development in apolipoprotein E-deficient mice-brief report. Arterioscler. Thromb. Vasc. Biol. 37, 1457\u20131461 (2017).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"957_CR75","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.cjca.2011.10.013","volume":"28","author":"J Gage","year":"2012","unstructured":"Gage, J., Hasu, M., Thabet, M. & Whitman, S. C. Caspase-1 deficiency decreases atherosclerosis in apolipoprotein E-null mice. Can. J. Cardiol. 28, 222\u2013229 (2012).","journal-title":"Can. J. Cardiol."},{"key":"957_CR76","doi-asserted-by":"publisher","first-page":"111847","DOI":"10.1016\/j.yexcr.2020.111847","volume":"389","author":"Y Li","year":"2020","unstructured":"Li, Y. et al. VX-765 attenuates atherosclerosis in ApoE deficient mice by modulating VSMCs pyroptosis. Exp. Cell Res. 389, 111847 (2020).","journal-title":"Exp. Cell Res."},{"key":"957_CR77","doi-asserted-by":"publisher","first-page":"E34","DOI":"10.1161\/hh0202.105292","volume":"90","author":"SC Whitman","year":"2002","unstructured":"Whitman, S. C., Ravisankar, P. & Daugherty, A. Interleukin-18 enhances atherosclerosis in apolipoprotein E\u2212\/\u2212 mice through release of interferon-\u03b3. Circ. Res. 90, E34\u2013E38 (2002).","journal-title":"Circ. Res."},{"key":"957_CR78","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/S0008-6363(03)00343-2","volume":"59","author":"R Elhage","year":"2003","unstructured":"Elhage, R. et al. Reduced atherosclerosis in interleukin-18 deficient apolipoprotein E-knockout mice. Cardiovasc. Res. 59, 234\u2013240 (2003).","journal-title":"Cardiovasc. Res."},{"key":"957_CR79","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1161\/01.ATV.0000064374.15232.C3","volume":"23","author":"H Kirii","year":"2003","unstructured":"Kirii, H. et al. Lack of interleukin-1\u03b2 decreases the severity of atherosclerosis in ApoE-deficient mice. Arterioscler. Thromb. Vasc. Biol. 23, 656\u2013660 (2003).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"957_CR80","doi-asserted-by":"publisher","first-page":"151940","DOI":"10.1016\/j.imbio.2020.151940","volume":"225","author":"MEA Borborema","year":"2020","unstructured":"Borborema, M. E. A., Crovella, S., Oliveira, D. & de Azev\u00eado Silva, J. Inflammasome activation by NLRP1 and NLRC4 in patients with coronary stenosis. Immunobiology 225, 151940 (2020).","journal-title":"Immunobiology"},{"key":"957_CR81","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/j.jvs.2013.03.048","volume":"59","author":"M Hakimi","year":"2014","unstructured":"Hakimi, M., Peters, A., Becker, A., B\u00f6ckler, D. & Dihlmann, S. Inflammation-related induction of absent in melanoma 2 (AIM2) in vascular cells and atherosclerotic lesions suggests a role in vascular pathogenesis. J. Vasc. Surg. 59, 794\u2013803 (2014).","journal-title":"J. Vasc. Surg."},{"key":"957_CR82","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1161\/CIRCULATIONAHA.117.033098","volume":"138","author":"N Paulin","year":"2018","unstructured":"Paulin, N. et al. Double-strand DNA sensing aim2 inflammasome regulates atherosclerotic plaque vulnerability. Circulation 138, 321\u2013323 (2018).","journal-title":"Circulation"},{"key":"957_CR83","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.bbrc.2018.03.005","volume":"498","author":"J Pan","year":"2018","unstructured":"Pan, J. et al. AIM2 accelerates the atherosclerotic plaque progressions in ApoE\u2212\/\u2212 mice. Biochem. Biophys. Res. Commun. 498, 487\u2013494 (2018).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"957_CR84","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon, S. J. et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell 149, 1060\u20131072 (2012).","journal-title":"Cell"},{"key":"957_CR85","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.cell.2017.09.021","volume":"171","author":"BR Stockwell","year":"2017","unstructured":"Stockwell, B. R. et al. Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease. Cell 171, 273\u2013285 (2017).","journal-title":"Cell"},{"key":"957_CR86","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","volume":"156","author":"WS Yang","year":"2014","unstructured":"Yang, W. S. et al. Regulation of ferroptotic cancer cell death by GPX4. Cell 156, 317\u2013331 (2014).","journal-title":"Cell"},{"key":"957_CR87","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/s41392-020-00428-9","volume":"6","author":"HF Yan","year":"2021","unstructured":"Yan, H. F. et al. Ferroptosis: mechanisms and links with diseases. Signal. Transduct. Target. Ther. 6, 49 (2021).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"957_CR88","doi-asserted-by":"publisher","first-page":"527","DOI":"10.3390\/biology12040527","volume":"12","author":"A Rasool","year":"2023","unstructured":"Rasool, A., Mahmoud, T. & O\u2019Tierney-Ginn, P. Lipid aldehydes 4-hydroxynonenal and 4-hydroxyhexenal exposure differentially impact lipogenic pathways in human placenta. Biology 12, 527 (2023).","journal-title":"Biology"},{"key":"957_CR89","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/j.bbadis.2007.04.009","volume":"1772","author":"GO Fruhwirth","year":"2007","unstructured":"Fruhwirth, G. O., Loidl, A. & Hermetter, A. Oxidized phospholipids: from molecular properties to disease. Biochim. Biophys. Acta 1772, 718\u2013736 (2007).","journal-title":"Biochim. Biophys. Acta"},{"key":"957_CR90","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.ccell.2019.04.002","volume":"35","author":"B Hassannia","year":"2019","unstructured":"Hassannia, B., Vandenabeele, P. & Vanden Berghe, T. Targeting ferroptosis to iron out cancer. Cancer Cell 35, 830\u2013849 (2019).","journal-title":"Cancer Cell"},{"key":"957_CR91","doi-asserted-by":"publisher","first-page":"2581","DOI":"10.1182\/blood-2017-12-822619","volume":"131","author":"LA Youssef","year":"2018","unstructured":"Youssef, L. A. et al. Increased erythrophagocytosis induces ferroptosis in red pulp macrophages in a mouse model of transfusion. Blood 131, 2581\u20132593 (2018).","journal-title":"Blood"},{"key":"957_CR92","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1161\/01.RES.0000020017.84398.61","volume":"90","author":"GR De Meyer","year":"2002","unstructured":"De Meyer, G. R. et al. Platelet phagocytosis and processing of \u03b2-amyloid precursor protein as a mechanism of macrophage activation in atherosclerosis. Circ. Res. 90, 1197\u20131204 (2002).","journal-title":"Circ. Res."},{"key":"957_CR93","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1161\/01.ATV.0000057807.28754.7F","volume":"23","author":"MM Kockx","year":"2003","unstructured":"Kockx, M. M. et al. Phagocytosis and macrophage activation associated with hemorrhagic microvessels in human atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 23, 440\u2013446 (2003).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"957_CR94","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1080\/10715760400011692","volume":"38","author":"XM Yuan","year":"2004","unstructured":"Yuan, X. M., Li, W., Baird, S. K., Carlsson, M. & Melefors, O. Secretion of ferritin by iron-laden macrophages and influence of lipoproteins. Free Radic. Res. 38, 1133\u20131142 (2004).","journal-title":"Free Radic. Res."},{"key":"957_CR95","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/0021-9150(96)05817-0","volume":"124","author":"XM Yuan","year":"1996","unstructured":"Yuan, X. M., Anders, W. L., Olsson, A. G. & Brunk, U. T. Iron in human atheroma and LDL oxidation by macrophages following erythrophagocytosis. Atherosclerosis 124, 61\u201373 (1996).","journal-title":"Atherosclerosis"},{"key":"957_CR96","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/0021-9150(94)90192-9","volume":"111","author":"B Fuhrman","year":"1994","unstructured":"Fuhrman, B., Oiknine, J. & Aviram, M. Iron induces lipid peroxidation in cultured macrophages, increases their ability to oxidatively modify LDL, and affects their secretory properties. Atherosclerosis 111, 65\u201378 (1994).","journal-title":"Atherosclerosis"},{"key":"957_CR97","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1161\/01.ATV.15.9.1345","volume":"15","author":"XM Yuan","year":"1995","unstructured":"Yuan, X. M., Brunk, U. T. & Olsson, A. G. Effects of iron- and hemoglobin-loaded human monocyte-derived macrophages on oxidation and uptake of LDL. Arterioscler. Thromb. Vasc. Biol. 15, 1345\u20131351 (1995).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"957_CR98","doi-asserted-by":"publisher","first-page":"119935","DOI":"10.1016\/j.lfs.2021.119935","volume":"284","author":"Z Meng","year":"2021","unstructured":"Meng, Z. et al. HMOX1 upregulation promotes ferroptosis in diabetic atherosclerosis. Life Sci. 284, 119935 (2021).","journal-title":"Life Sci."},{"key":"957_CR99","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.2741\/3297","volume":"14","author":"KK David","year":"2009","unstructured":"David, K. K., Andrabi, S. A., Dawson, T. M. & Dawson, V. L. Parthanatos, a messenger of death. Front. Biosci. 14, 1116\u20131128 (2009).","journal-title":"Front. Biosci."},{"key":"957_CR100","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1161\/hh0701.088684","volume":"88","author":"W Martinet","year":"2001","unstructured":"Martinet, W., Knaapen, M. W., De Meyer, G. R., Herman, A. G. & Kockx, M. M. Oxidative DNA damage and repair in experimental atherosclerosis are reversed by dietary lipid lowering. Circ. Res. 88, 733\u2013739 (2001).","journal-title":"Circ. Res."},{"key":"957_CR101","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1161\/01.CIR.0000026393.47805.21","volume":"106","author":"W Martinet","year":"2002","unstructured":"Martinet, W., Knaapen, M. W., De Meyer, G. R., Herman, A. G. & Kockx, M. M. Elevated levels of oxidative DNA damage and DNA repair enzymes in human atherosclerotic plaques. Circulation 106, 927\u2013932 (2002).","journal-title":"Circulation"},{"key":"957_CR102","doi-asserted-by":"publisher","first-page":"2442","DOI":"10.1161\/CIRCULATIONAHA.106.668756","volume":"115","author":"K Oumouna-Benachour","year":"2007","unstructured":"Oumouna-Benachour, K. et al. Poly(ADP-ribose) polymerase inhibition reduces atherosclerotic plaque size and promotes factors of plaque stability in apolipoprotein E-deficient mice: effects on macrophage recruitment, nuclear factor-kappaB nuclear translocation, and foam cell death. Circulation 115, 2442\u20132450 (2007).","journal-title":"Circulation"},{"key":"957_CR103","doi-asserted-by":"publisher","first-page":"641","DOI":"10.5551\/jat.1586","volume":"16","author":"JJ Xie","year":"2009","unstructured":"Xie, J. J. et al. Poly (ADP-ribose) polymerase inhibition attenuates atherosclerotic plaque development in ApoE-\/- mice with hyperhomocysteinemia. J. Atheroscler. Thromb. 16, 641\u2013653 (2009).","journal-title":"J. Atheroscler. Thromb."},{"key":"957_CR104","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/cdd.2014.143","volume":"22","author":"Y Liu","year":"2015","unstructured":"Liu, Y. & Levine, B. Autosis and autophagic cell death: the dark side of autophagy. Cell Death Differ. 22, 367\u2013376 (2015).","journal-title":"Cell Death Differ."},{"key":"957_CR105","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.jacbts.2020.04.014","volume":"5","author":"J Nah","year":"2020","unstructured":"Nah, J., Zablocki, D. & Sadoshima, J. Autosis: a new target to prevent cell death. JACC Basic Transl. Sci. 5, 857\u2013869 (2020).","journal-title":"JACC Basic Transl. Sci."},{"key":"957_CR106","doi-asserted-by":"publisher","DOI":"10.1186\/s12950-019-0212-4","volume":"16","author":"M Hassanpour","year":"2019","unstructured":"Hassanpour, M. et al. Role of autophagy in atherosclerosis: foe or friend? J. Inflamm. 16, 8 (2019).","journal-title":"J. Inflamm."},{"key":"957_CR107","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1161\/CIRCRESAHA.116.303804","volume":"116","author":"GRY De Meyer","year":"2015","unstructured":"De Meyer, G. R. Y. et al. Autophagy in vascular disease. Circ. Res. 116, 468\u2013479 (2015).","journal-title":"Circ. Res."},{"key":"957_CR108","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1161\/01.ATV.0000251503.35795.4f","volume":"27","author":"W Koenig","year":"2007","unstructured":"Koenig, W. & Khuseyinova, N. Biomarkers of atherosclerotic plaque instability and rupture. Arterioscler. Thromb. Vasc. Biol. 27, 15\u201326 (2007).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"957_CR109","first-page":"439","volume":"29","author":"SS Bassuk","year":"2004","unstructured":"Bassuk, S. S., Rifai, N. & Ridker, P. M. High-sensitivity C-reactive protein: clinical importance. Curr. Probl. Cardiol. 29, 439\u2013493 (2004).","journal-title":"Curr. Probl. Cardiol."},{"key":"957_CR110","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1016\/S0140-6736(10)60319-4","volume":"375","author":"A Thompson","year":"2010","unstructured":"Thompson, A. et al. Lipoprotein-associated phospholipase A2 and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies. Lancet 375, 1536\u20131544 (2010).","journal-title":"Lancet"},{"key":"957_CR111","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.cca.2019.10.003","volume":"500","author":"K Wimmer","year":"2020","unstructured":"Wimmer, K., Sachet, M. & Oehler, R. Circulating biomarkers of cell death. Clin. Chim. Acta 500, 87\u201397 (2020).","journal-title":"Clin. Chim. Acta"},{"key":"957_CR112","doi-asserted-by":"publisher","first-page":"1983421","DOI":"10.1155\/2018\/1983421","volume":"2018","author":"M Vucur","year":"2018","unstructured":"Vucur, M. et al. Elevated serum levels of mixed lineage kinase domain-like protein predict survival of patients during intensive care unit treatment. Dis. Markers 2018, 1983421 (2018).","journal-title":"Dis. Markers"},{"key":"957_CR113","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-018-4655-4","volume":"18","author":"B Hu","year":"2018","unstructured":"Hu, B. et al. Prognostic and clinicopathological significance of MLKL expression in cancer patients: a meta-analysis. BMC Cancer 18, 736 (2018).","journal-title":"BMC Cancer"},{"key":"957_CR114","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.2063","volume":"11","author":"H Shen","year":"2021","unstructured":"Shen, H. et al. Pyroptosis executive protein GSDMD as a biomarker for diagnosis and identification of Alzheimer\u2019s disease. Brain Behav. 11, e02063 (2021).","journal-title":"Brain Behav."},{"key":"957_CR115","doi-asserted-by":"publisher","first-page":"3185","DOI":"10.2147\/JIR.S319213","volume":"14","author":"D Wang","year":"2021","unstructured":"Wang, D. et al. Assessment of pyroptosis-related indicators as potential biomarkers and their association with severity in patients with liver cirrhosis. J. Inflamm. Res. 14, 3185\u20133196 (2021).","journal-title":"J. Inflamm. Res."},{"key":"957_CR116","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/s41422-020-00441-1","volume":"31","author":"D Tang","year":"2021","unstructured":"Tang, D., Chen, X., Kang, R. & Kroemer, G. Ferroptosis: molecular mechanisms and health implications. Cell Res. 31, 107\u2013125 (2021).","journal-title":"Cell Res."},{"key":"957_CR117","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-03118-0","volume":"11","author":"B Wiernicki","year":"2020","unstructured":"Wiernicki, B. et al. Excessive phospholipid peroxidation distinguishes ferroptosis from other cell death modes including pyroptosis. Cell Death Dis. 11, 922 (2020).","journal-title":"Cell Death Dis."},{"key":"957_CR118","doi-asserted-by":"publisher","first-page":"6827","DOI":"10.3390\/ijms21186827","volume":"21","author":"M Szil\u00e1gyi","year":"2020","unstructured":"Szil\u00e1gyi, M. et al. Circulating cell-free nucleic acids: main characteristics and clinical application. Int. J. Mol. Sci. 21, 6827 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"957_CR119","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.cca.2020.01.013","volume":"503","author":"IA Polina","year":"2020","unstructured":"Polina, I. A., Ilatovskaya, D. V. & DeLeon-Pennell, K. Y. Cell free DNA as a diagnostic and prognostic marker for cardiovascular diseases. Clin. Chim. Acta 503, 145\u2013150 (2020).","journal-title":"Clin. Chim. Acta"},{"key":"957_CR120","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-03961-y","volume":"9","author":"H Zemmour","year":"2018","unstructured":"Zemmour, H. et al. Non-invasive detection of human cardiomyocyte death using methylation patterns of circulating DNA. Nat. Commun. 9, 1443 (2018).","journal-title":"Nat. Commun."},{"key":"957_CR121","doi-asserted-by":"publisher","first-page":"2992","DOI":"10.3390\/ijms21082992","volume":"21","author":"NV Mushenkova","year":"2020","unstructured":"Mushenkova, N. V. et al. Current advances in the diagnostic imaging of atherosclerosis: insights into the pathophysiology of vulnerable plaque. Int. J. Mol. Sci. 21, 2992 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"957_CR122","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1021\/acsmedchemlett.9b00677","volume":"11","author":"C De Dominicis","year":"2020","unstructured":"De Dominicis, C. et al. [18F]ZCDD083: a PFKFB3-targeted PET tracer for atherosclerotic plaque imaging. ACS Med. Chem. Lett. 11, 933\u2013939 (2020).","journal-title":"ACS Med. Chem. Lett."},{"key":"957_CR123","doi-asserted-by":"publisher","first-page":"2979","DOI":"10.2147\/IJGM.S346482","volume":"15","author":"H Liu","year":"2022","unstructured":"Liu, H., Xiang, C., Wang, Z. & Song, Y. Identification of potential ferroptosis-related biomarkers and immune infiltration in human coronary artery atherosclerosis. Int. J. Gen. Med. 15, 2979\u20132990 (2022).","journal-title":"Int. J. Gen. Med."},{"key":"957_CR124","doi-asserted-by":"publisher","first-page":"306","DOI":"10.3389\/fphar.2019.00306","volume":"10","author":"W Martinet","year":"2019","unstructured":"Martinet, W., Coornaert, I., Puylaert, P. & De Meyer, G. R. Y. Macrophage death as a pharmacological target in atherosclerosis. Front. Pharmacol. 10, 306 (2019).","journal-title":"Front. Pharmacol."},{"key":"957_CR125","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1124\/jpet.106.113944","volume":"320","author":"V Croons","year":"2007","unstructured":"Croons, V., Martinet, W., Herman, A. G., Timmermans, J. P. & De Meyer, G. R. Selective clearance of macrophages in atherosclerotic plaques by the protein synthesis inhibitor cycloheximide. J. Pharmacol. Exp. Ther. 320, 986\u2013993 (2007).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"957_CR126","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1161\/CIRCULATIONAHA.116.025684","volume":"135","author":"Y Kojima","year":"2017","unstructured":"Kojima, Y., Weissman, I. L. & Leeper, N. J. The role of efferocytosis in atherosclerosis. Circulation 135, 476\u2013489 (2017).","journal-title":"Circulation"},{"key":"957_CR127","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.bbamcr.2014.12.014","volume":"1853","author":"E Garabuczi","year":"2015","unstructured":"Garabuczi, E., Sarang, Z. & Szondy, Z. Glucocorticoids enhance prolonged clearance of apoptotic cells by upregulating liver X receptor, peroxisome proliferator-activated receptor-\u03b4 and UCP2. Biochim. Biophys. Acta 1853, 573\u2013582 (2015).","journal-title":"Biochim. Biophys. Acta"},{"key":"957_CR128","doi-asserted-by":"publisher","first-page":"3727","DOI":"10.4049\/jimmunol.174.6.3727","volume":"174","author":"P Maderna","year":"2005","unstructured":"Maderna, P., Yona, S., Perretti, M. & Godson, C. Modulation of phagocytosis of apoptotic neutrophils by supernatant from dexamethasone-treated macrophages and annexin-derived peptide Ac(2-26). J. Immunol. 174, 3727\u20133733 (2005).","journal-title":"J. Immunol."},{"key":"957_CR129","doi-asserted-by":"publisher","first-page":"4595","DOI":"10.4049\/jimmunol.178.7.4595","volume":"178","author":"M Scannell","year":"2007","unstructured":"Scannell, M. et al. Annexin-1 and peptide derivatives are released by apoptotic cells and stimulate phagocytosis of apoptotic neutrophils by macrophages. J. Immunol. 178, 4595\u20134605 (2007).","journal-title":"J. Immunol."},{"key":"957_CR130","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12859","volume":"7","author":"G Fredman","year":"2016","unstructured":"Fredman, G. et al. An imbalance between specialized pro-resolving lipid mediators and pro-inflammatory leukotrienes promotes instability of atherosclerotic plaques. Nat. Commun. 7, 12859 (2016).","journal-title":"Nat. Commun."},{"key":"957_CR131","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1161\/ATVBAHA.115.305324","volume":"35","author":"H Hasturk","year":"2015","unstructured":"Hasturk, H. et al. Resolvin E1 (RvE1) attenuates atherosclerotic plaque formation in diet and inflammation-induced atherogenesis. Arterioscler. Thromb. Vasc. Biol. 35, 1123\u20131133 (2015).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"957_CR132","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1161\/CIRCRESAHA.116.309492","volume":"119","author":"JR Viola","year":"2016","unstructured":"Viola, J. R. et al. Resolving lipid mediators maresin 1 and resolvin D2 prevent atheroprogression in mice. Circ. Res. 119, 1030\u20131038 (2016).","journal-title":"Circ. Res."},{"key":"957_CR133","first-page":"4037","volume":"126","author":"HN Lee","year":"2013","unstructured":"Lee, H. N., Kundu, J. K., Cha, Y. N. & Surh, Y. J. Resolvin D1 stimulates efferocytosis through p50\/p50-mediated suppression of tumor necrosis factor-\u03b1 expression. J. Cell Sci. 126, 4037\u20134047 (2013).","journal-title":"J. Cell Sci."},{"key":"957_CR134","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1042\/BJ20110327","volume":"437","author":"G Fredman","year":"2011","unstructured":"Fredman, G. & Serhan, C. N. Specialized proresolving mediator targets for RvE1 and RvD1 in peripheral blood and mechanisms of resolution. Biochem. J. 437, 185\u2013197 (2011).","journal-title":"Biochem. J."},{"key":"957_CR135","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/ni.2205","volume":"13","author":"JM van Gils","year":"2012","unstructured":"van Gils, J. M. et al. The neuroimmune guidance cue netrin-1 promotes atherosclerosis by inhibiting the emigration of macrophages from plaques. Nat. Immunol. 13, 136\u2013143 (2012).","journal-title":"Nat. Immunol."},{"key":"957_CR136","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1161\/CIRCRESAHA.121.319313","volume":"129","author":"M Schlegel","year":"2021","unstructured":"Schlegel, M. et al. Silencing myeloid netrin-1 induces inflammation resolution and plaque regression. Circ. Res. 129, 530\u2013546 (2021).","journal-title":"Circ. Res."},{"key":"957_CR137","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1161\/ATVBAHA.112.300941","volume":"33","author":"A Wanschel","year":"2013","unstructured":"Wanschel, A. et al. Neuroimmune guidance cue Semaphorin 3E is expressed in atherosclerotic plaques and regulates macrophage retention. Arterioscler. Thromb. Vasc. Biol. 33, 886\u2013893 (2013).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"957_CR138","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.immuni.2018.07.015","volume":"49","author":"JD Proto","year":"2018","unstructured":"Proto, J. D. et al. Regulatory T cells promote macrophage efferocytosis during inflammation resolution. Immunity 49, 666\u2013677.e6 (2018).","journal-title":"Immunity"},{"key":"957_CR139","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1161\/CIRCULATIONAHA.118.038379","volume":"143","author":"D Karunakaran","year":"2021","unstructured":"Karunakaran, D. et al. RIPK1 expression associates with inflammation in early atherosclerosis in humans and can be therapeutically silenced to reduce NF-\u03baB activation and atherogenesis in mice. Circulation 143, 163\u2013177 (2021).","journal-title":"Circulation"},{"key":"957_CR140","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.3390\/biomedicines10051016","volume":"10","author":"P Puylaert","year":"2022","unstructured":"Puylaert, P. et al. The impact of RIPK1 kinase inhibition on atherogenesis: a genetic and a pharmacological approach. Biomedicines 10, 1016 (2022).","journal-title":"Biomedicines"},{"key":"957_CR141","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1161\/ATVBAHA.119.313640","volume":"40","author":"A Rasheed","year":"2020","unstructured":"Rasheed, A. et al. Loss of MLKL (mixed lineage kinase domain-like protein) decreases necrotic core but increases macrophage lipid accumulation in atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 40, 1155\u20131167 (2020).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"957_CR142","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1161\/ATVBAHA.120.315758","volume":"41","author":"Z Hosseini","year":"2021","unstructured":"Hosseini, Z. et al. Resolvin D1 enhances necroptotic cell clearance through promoting macrophage fatty acid oxidation and oxidative phosphorylation. Arterioscler. Thromb. Vasc. Biol. 41, 1062\u20131075 (2021).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"957_CR143","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.celrep.2012.12.012","volume":"3","author":"J Lin","year":"2013","unstructured":"Lin, J. et al. A role of RIP3-mediated macrophage necrosis in atherosclerosis development. Cell Rep. 3, 200\u2013210 (2013).","journal-title":"Cell Rep."},{"key":"957_CR144","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","volume":"377","author":"PM Ridker","year":"2017","unstructured":"Ridker, P. M. et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N. Engl. J. Med. 377, 1119\u20131131 (2017).","journal-title":"N. Engl. J. Med."},{"key":"957_CR145","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.atherosclerosis.2011.02.026","volume":"216","author":"V Bhaskar","year":"2011","unstructured":"Bhaskar, V. et al. Monoclonal antibodies targeting IL-1 beta reduce biomarkers of atherosclerosis in vitro and inhibit atherosclerotic plaque formation in Apolipoprotein E-deficient mice. Atherosclerosis 216, 313\u2013320 (2011).","journal-title":"Atherosclerosis"},{"key":"957_CR146","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1038\/s41591-018-0124-5","volume":"24","author":"D Gomez","year":"2018","unstructured":"Gomez, D. et al. Interleukin-1\u03b2 has atheroprotective effects in advanced atherosclerotic lesions of mice. Nat. Med. 24, 1418\u20131429 (2018).","journal-title":"Nat. Med."},{"key":"957_CR147","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1093\/eurheartj\/ehz542","volume":"41","author":"PM Ridker","year":"2019","unstructured":"Ridker, P. M., MacFadyen, J. G., Thuren, T. & Libby, P. Residual inflammatory risk associated with interleukin-18 and interleukin-6 after successful interleukin-1\u03b2 inhibition with canakinumab: further rationale for the development of targeted anti-cytokine therapies for the treatment of atherothrombosis. Eur. Heart J. 41, 2153\u20132163 (2019).","journal-title":"Eur. Heart J."},{"key":"957_CR148","first-page":"495","volume":"29","author":"T Koritala","year":"2021","unstructured":"Koritala, T. et al. Infection risk with the use of interleukin inhibitors in hospitalized patients with COVID-19: a narrative review. Infez. Med. 29, 495\u2013503 (2021).","journal-title":"Infez. Med."},{"key":"957_CR149","doi-asserted-by":"publisher","first-page":"695","DOI":"10.21037\/jtd.2018.01.119","volume":"10","author":"PL Thompson","year":"2018","unstructured":"Thompson, P. L. & Nidorf, S. M. Anti-inflammatory therapy with canakinumab for atherosclerotic disease: lessons from the CANTOS trial. J. Thorac. Dis. 10, 695\u2013698 (2018).","journal-title":"J. Thorac. Dis."},{"key":"957_CR150","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.jacbts.2021.08.006","volume":"7","author":"MB Olsen","year":"2022","unstructured":"Olsen, M. B. et al. Targeting the inflammasome in cardiovascular disease. JACC Basic Transl. Sci. 7, 84\u201398 (2022).","journal-title":"JACC Basic Transl. Sci."},{"key":"957_CR151","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.115.002128","volume":"4","author":"GJ Martinez","year":"2015","unstructured":"Martinez, G. J. et al. Colchicine acutely suppresses local cardiac production of inflammatory cytokines in patients with an acute coronary syndrome. J. Am. Heart Assoc. 4, e002128 (2015).","journal-title":"J. Am. Heart Assoc."},{"key":"957_CR152","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.amjcard.2006.10.039","volume":"99","author":"M Nidorf","year":"2007","unstructured":"Nidorf, M. & Thompson, P. L. Effect of colchicine (0.5 mg twice daily) on high-sensitivity C-reactive protein independent of aspirin and atorvastatin in patients with stable coronary artery disease. Am. J. Cardiol. 99, 805\u2013807 (2007).","journal-title":"Am. J. Cardiol."},{"key":"957_CR153","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.jacc.2012.10.027","volume":"61","author":"SM Nidorf","year":"2013","unstructured":"Nidorf, S. M., Eikelboom, J. W., Budgeon, C. A. & Thompson, P. L. Low-dose colchicine for secondary prevention of cardiovascular disease. J. Am. Coll. Cardiol. 61, 404\u2013410 (2013).","journal-title":"J. Am. Coll. Cardiol."},{"key":"957_CR154","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1038\/s41569-022-00755-0","volume":"19","author":"O Soehnlein","year":"2022","unstructured":"Soehnlein, O. & Tall, A. R. AIMing 2 treat atherosclerosis. Nat. Rev. Cardiol. 19, 567\u2013568 (2022).","journal-title":"Nat. Rev. Cardiol."},{"key":"957_CR155","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.immuni.2017.11.013","volume":"48","author":"CL Evavold","year":"2018","unstructured":"Evavold, C. L. et al. The pore-forming protein gasdermin D regulates interleukin-1 secretion from living macrophages. Immunity 48, 35\u201344.e36 (2018).","journal-title":"Immunity"},{"key":"957_CR156","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1038\/s41590-020-0669-6","volume":"21","author":"JJ Hu","year":"2020","unstructured":"Hu, J. J. et al. FDA-approved disulfiram inhibits pyroptosis by blocking gasdermin D pore formation. Nat. Immunol. 21, 736\u2013745 (2020).","journal-title":"Nat. Immunol."},{"key":"957_CR157","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1126\/science.abb9818","volume":"369","author":"F Humphries","year":"2020","unstructured":"Humphries, F. et al. Succination inactivates gasdermin D and blocks pyroptosis. Science 369, 1633\u20131637 (2020).","journal-title":"Science"},{"key":"957_CR158","doi-asserted-by":"publisher","first-page":"7966","DOI":"10.12659\/MSM.918951","volume":"25","author":"M Luo","year":"2019","unstructured":"Luo, M., Sun, Q., Zhao, H., Tao, J. & Yan, D. The effects of dimethyl fumarate on atherosclerosis in the apolipoprotein E-Deficient mouse model with streptozotocin-induced hyperglycemia mediated by the nuclear factor erythroid 2-related factor 2\/antioxidant response element (Nrf2\/ARE) signaling pathway. Med. Sci. Monit. 25, 7966\u20137975 (2019).","journal-title":"Med. Sci. Monit."},{"key":"957_CR159","doi-asserted-by":"publisher","first-page":"3504","DOI":"10.1007\/s00395-013-0350-4","volume":"108","author":"V Matheeussen","year":"2013","unstructured":"Matheeussen, V. et al. Dipeptidyl peptidases in atherosclerosis: expression and role in macrophage differentiation, activation and apoptosis. Basic Res. Cardiol. 108, 3504 (2013).","journal-title":"Basic Res. Cardiol."},{"key":"957_CR160","doi-asserted-by":"publisher","first-page":"175566","DOI":"10.1016\/j.ejphar.2023.175566","volume":"944","author":"A Wisniewska","year":"2023","unstructured":"Wisniewska, A. et al. The antiatherosclerotic action of 1G244 - An inhibitor of dipeptidyl peptidases 8\/9 - is mediated by the induction of macrophage death. Eur. J. Pharmacol. 944, 175566 (2023).","journal-title":"Eur. J. Pharmacol."},{"key":"957_CR161","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1038\/ncb3064","volume":"16","author":"JP Friedmann Angeli","year":"2014","unstructured":"Friedmann Angeli, J. P. et al. Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice. Nat. Cell Biol. 16, 1180\u20131191 (2014).","journal-title":"Nat. Cell Biol."},{"key":"957_CR162","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1021\/acscentsci.7b00028","volume":"3","author":"O Zilka","year":"2017","unstructured":"Zilka, O. et al. On the mechanism of cytoprotection by ferrostatin-1 and liproxstatin-1 and the role of lipid peroxidation in ferroptotic cell death. ACS Cent. Sci. 3, 232\u2013243 (2017).","journal-title":"ACS Cent. Sci."},{"key":"957_CR163","doi-asserted-by":"publisher","first-page":"4551","DOI":"10.1021\/ja411006a","volume":"136","author":"R Skouta","year":"2014","unstructured":"Skouta, R. et al. Ferrostatins inhibit oxidative lipid damage and cell death in diverse disease models. J. Am. Chem. Soc. 136, 4551\u20134556 (2014).","journal-title":"J. Am. Chem. Soc."},{"key":"957_CR164","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.freeradbiomed.2020.07.026","volume":"160","author":"T Bai","year":"2020","unstructured":"Bai, T., Li, M., Liu, Y., Qiao, Z. & Wang, Z. Inhibition of ferroptosis alleviates atherosclerosis through attenuating lipid peroxidation and endothelial dysfunction in mouse aortic endothelial cell. Free Radic. Biol. Med. 160, 92\u2013102 (2020).","journal-title":"Free Radic. Biol. Med."},{"key":"957_CR165","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.freeradbiomed.2007.09.009","volume":"44","author":"Z Guo","year":"2008","unstructured":"Guo, Z. et al. Suppression of atherogenesis by overexpression of glutathione peroxidase-4 in apolipoprotein E-deficient mice. Free Radic. Biol. Med. 44, 343\u2013352 (2008).","journal-title":"Free Radic. Biol. Med."},{"key":"957_CR166","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1021\/acs.jmedchem.5b01641","volume":"59","author":"S Hofmans","year":"2016","unstructured":"Hofmans, S. et al. Novel ferroptosis inhibitors with improved potency and ADME properties. J. Med. Chem. 59, 2041\u20132053 (2016).","journal-title":"J. Med. Chem."},{"key":"957_CR167","doi-asserted-by":"publisher","first-page":"10126","DOI":"10.1021\/acs.jmedchem.8b01299","volume":"61","author":"L Devisscher","year":"2018","unstructured":"Devisscher, L. et al. Discovery of novel, drug-like ferroptosis inhibitors with in vivo efficacy. J. Med. Chem. 61, 10126\u201310140 (2018).","journal-title":"J. Med. Chem."},{"key":"957_CR168","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s10456-023-09877-6","volume":"26","author":"P Puylaert","year":"2023","unstructured":"Puylaert, P. et al. Effect of erythrophagocytosis-induced ferroptosis during angiogenesis in atherosclerotic plaques. Angiogenesis 26, 505\u2013522 (2023).","journal-title":"Angiogenesis"},{"key":"957_CR169","doi-asserted-by":"publisher","first-page":"289","DOI":"10.3892\/etm.2023.11988","volume":"25","author":"J Xu","year":"2023","unstructured":"Xu, J., Han, X., Xia, N., Zhao, Q. & Cheng, Z. IL-37 suppresses macrophage ferroptosis to attenuate diabetic atherosclerosis via the NRF2 pathway. Exp. Ther. Med. 25, 289 (2023).","journal-title":"Exp. Ther. Med."},{"key":"957_CR170","doi-asserted-by":"publisher","first-page":"3448","DOI":"10.1016\/j.bbamcr.2013.06.001","volume":"1833","author":"V Nikoletopoulou","year":"2013","unstructured":"Nikoletopoulou, V., Markaki, M., Palikaras, K. & Tavernarakis, N. Crosstalk between apoptosis, necrosis and autophagy. Biochim. Biophys. Acta 1833, 3448\u20133459 (2013).","journal-title":"Biochim. Biophys. Acta"},{"key":"957_CR171","doi-asserted-by":"publisher","first-page":"2514","DOI":"10.1101\/gad.13.19.2514","volume":"13","author":"Y Lin","year":"1999","unstructured":"Lin, Y., Devin, A., Rodriguez, Y. & Liu, Z. G. Cleavage of the death domain kinase RIP by caspase-8 prompts TNF-induced apoptosis. Genes Dev. 13, 2514\u20132526 (1999).","journal-title":"Genes Dev."},{"key":"957_CR172","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/nrm3683","volume":"14","author":"D Ofengeim","year":"2013","unstructured":"Ofengeim, D. & Yuan, J. Regulation of RIP1 kinase signalling at the crossroads of inflammation and cell death. Nat. Rev. Mol. Cell Biol. 14, 727\u2013736 (2013).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"957_CR173","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1038\/s41586-019-1770-6","volume":"575","author":"M Fritsch","year":"2019","unstructured":"Fritsch, M. et al. Caspase-8 is the molecular switch for apoptosis, necroptosis and pyroptosis. Nature 575, 683\u2013687 (2019).","journal-title":"Nature"},{"key":"957_CR174","doi-asserted-by":"publisher","first-page":"3846","DOI":"10.1016\/j.celrep.2017.12.018","volume":"21","author":"KS Schneider","year":"2017","unstructured":"Schneider, K. S. et al. The inflammasome drives GSDMD-independent secondary pyroptosis and IL-1 release in the absence of caspase-1 protease activity. Cell Rep. 21, 3846\u20133859 (2017).","journal-title":"Cell Rep."},{"key":"957_CR175","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.semcdb.2020.07.011","volume":"109","author":"M Speir","year":"2021","unstructured":"Speir, M. & Lawlor, K. E. RIP-roaring inflammation: RIPK1 and RIPK3 driven NLRP3 inflammasome activation and autoinflammatory disease. Semin. Cell Dev. Biol. 109, 114\u2013124 (2021).","journal-title":"Semin. Cell Dev. Biol."},{"key":"957_CR176","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7282","volume":"6","author":"KE Lawlor","year":"2015","unstructured":"Lawlor, K. E. et al. RIPK3 promotes cell death and NLRP3 inflammasome activation in the absence of MLKL. Nat. Commun. 6, 6282 (2015).","journal-title":"Nat. Commun."},{"key":"957_CR177","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-0694-7","volume":"9","author":"L Tao","year":"2018","unstructured":"Tao, L. et al. The kinase receptor-interacting protein 1 is required for inflammasome activation induced by endoplasmic reticulum stress. Cell Death Dis. 9, 641 (2018).","journal-title":"Cell Death Dis."},{"key":"957_CR178","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.3390\/biomedicines10051171","volume":"10","author":"P Puylaert","year":"2022","unstructured":"Puylaert, P. et al. Gasdermin D deficiency limits the transition of atherosclerotic plaques to an inflammatory phenotype in ApoE knock-out mice. Biomedicines 10, 1171 (2022).","journal-title":"Biomedicines"},{"key":"957_CR179","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1111\/imr.12909","volume":"297","author":"M Zheng","year":"2020","unstructured":"Zheng, M. & Kanneganti, T. D. The regulation of the ZBP1-NLRP3 inflammasome and its implications in pyroptosis, apoptosis, and necroptosis (PANoptosis). Immunol. Rev. 297, 26\u201338 (2020).","journal-title":"Immunol. Rev."},{"key":"957_CR180","doi-asserted-by":"publisher","DOI":"10.1172\/JCI155724","volume":"132","author":"W Liu","year":"2022","unstructured":"Liu, W. et al. Erythroid lineage Jak2V617F expression promotes atherosclerosis through erythrophagocytosis and macrophage ferroptosis. J. Clin. Invest. 132, e155724 (2022).","journal-title":"J. Clin. Invest."},{"key":"957_CR181","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1093\/eurheartj\/ehr054","volume":"32","author":"JB Michel","year":"2011","unstructured":"Michel, J. B., Virmani, R., Arbustini, E. & Pasterkamp, G. Intraplaque haemorrhages as the trigger of plaque vulnerability. Eur. Heart J. 32, 1977\u20131985 (2011).","journal-title":"Eur. Heart J."},{"key":"957_CR182","doi-asserted-by":"publisher","first-page":"E4110","DOI":"10.1073\/pnas.1405023111","volume":"111","author":"FF Dutra","year":"2014","unstructured":"Dutra, F. F. et al. Hemolysis-induced lethality involves inflammasome activation by heme. Proc. Natl Acad. Sci. USA 111, E4110\u2013E4118 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"957_CR183","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.2174\/1381612054065783","volume":"11","author":"A Cherubini","year":"2005","unstructured":"Cherubini, A. et al. Role of antioxidants in atherosclerosis: epidemiological and clinical update. Curr. Pharm. Des. 11, 2017\u20132032 (2005).","journal-title":"Curr. Pharm. Des."},{"key":"957_CR184","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1007\/s12272-010-1114-4","volume":"33","author":"HJ Kim","year":"2010","unstructured":"Kim, H. J. et al. NecroX as a novel class of mitochondrial reactive oxygen species and ONOO- scavenger. Arch. Pharm. Res. 33, 1813\u20131823 (2010).","journal-title":"Arch. Pharm. Res."},{"key":"957_CR185","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.atherosclerosis.2016.06.045","volume":"252","author":"MO Grootaert","year":"2016","unstructured":"Grootaert, M. O. et al. NecroX-7 reduces necrotic core formation in atherosclerotic plaques of Apoe knockout mice. Atherosclerosis 252, 166\u2013174 (2016).","journal-title":"Atherosclerosis"},{"key":"957_CR186","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1016\/j.clinthera.2020.08.011","volume":"42","author":"E Kim","year":"2020","unstructured":"Kim, E. et al. Pharmacokinetics and tolerability of LC28-0126, a novel necrosis inhibitor, after multiple ascending doses: a phase I randomized, double-blind, placebo-controlled study in healthy male subjects. Clin. Ther. 42, 1946\u20131954.e2 (2020).","journal-title":"Clin. Ther."},{"key":"957_CR187","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1016\/j.jacc.2021.03.307","volume":"77","author":"D Marlevi","year":"2021","unstructured":"Marlevi, D. & Edelman, E. R. Vascular lesion-specific drug delivery systems: JACC state-of-the-art review. J. Am. Coll. Cardiol. 77, 2413\u20132431 (2021).","journal-title":"J. Am. Coll. Cardiol."},{"key":"957_CR188","doi-asserted-by":"publisher","first-page":"4710","DOI":"10.7150\/thno.26284","volume":"8","author":"J Bejarano","year":"2018","unstructured":"Bejarano, J. et al. Nanoparticles for diagnosis and therapy of atherosclerosis and myocardial infarction: evolution toward prospective theranostic approaches. Theranostics 8, 4710\u20134732 (2018).","journal-title":"Theranostics"},{"key":"957_CR189","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17915-w","volume":"11","author":"H Tao","year":"2020","unstructured":"Tao, H. et al. Scavenging of reactive dicarbonyls with 2-hydroxybenzylamine reduces atherosclerosis in hypercholesterolemic Ldlr-\/- mice. Nat. Commun. 11, 4084 (2020).","journal-title":"Nat. Commun."},{"key":"957_CR190","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s40360-020-0382-y","volume":"21","author":"LM Pitchford","year":"2020","unstructured":"Pitchford, L. M. et al. Safety, tolerability, and pharmacokinetics of repeated oral doses of 2-hydroxybenzylamine acetate in healthy volunteers: a double-blind, randomized, placebo-controlled clinical trial. BMC Pharmacol. Toxicol. 21, 3 (2020).","journal-title":"BMC Pharmacol. Toxicol."},{"key":"957_CR191","doi-asserted-by":"publisher","first-page":"101651","DOI":"10.1016\/j.molmet.2022.101651","volume":"67","author":"J Huang","year":"2023","unstructured":"Huang, J. et al. Scavenging dicarbonyls with 5\u2019-O-pentyl-pyridoxamine increases HDL net cholesterol efflux capacity and attenuates atherosclerosis and insulin resistance. Mol. Metab. 67, 101651 (2023).","journal-title":"Mol. Metab."},{"key":"957_CR192","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.tcm.2006.12.004","volume":"17","author":"W Martinet","year":"2007","unstructured":"Martinet, W., Verheye, S. & De Meyer, G. R. Y. Selective depletion of macrophages in atherosclerotic plaques via macrophage-specific initiation of cell death. Trends Cardiovasc. Med. 17, 69\u201375 (2007).","journal-title":"Trends Cardiovasc. Med."},{"key":"957_CR193","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/j.jacc.2006.09.047","volume":"49","author":"S Verheye","year":"2007","unstructured":"Verheye, S. et al. Selective clearance of macrophages in atherosclerotic plaques by autophagy. J. Am. Coll. Cardiol. 49, 706\u2013715 (2007).","journal-title":"J. Am. Coll. Cardiol."},{"key":"957_CR194","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.3892\/ijmm.2013.1494","volume":"32","author":"X Wang","year":"2013","unstructured":"Wang, X. et al. Knockdown of mTOR by lentivirus-mediated RNA interference suppresses atherosclerosis and stabilizes plaques via a decrease of macrophages by autophagy in apolipoprotein E-deficient mice. Int. J. Mol. Med. 32, 1215\u20131221 (2013).","journal-title":"Int. J. Mol. Med."},{"key":"957_CR195","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0090563","volume":"9","author":"C Zhai","year":"2014","unstructured":"Zhai, C. et al. Selective inhibition of PI3K\/Akt\/mTOR signaling pathway regulates autophagy of macrophage and vulnerability of atherosclerotic plaque. PLoS ONE\u00a09, e90563 (2014).","journal-title":"PLoS ONE"},{"key":"957_CR196","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s00395-012-0321-1","volume":"108","author":"W Martinet","year":"2013","unstructured":"Martinet, W. et al. Drug-induced macrophage autophagy in atherosclerosis: for better or worse? Basic Res. Cardiol. 108, 321 (2013).","journal-title":"Basic Res. Cardiol."},{"key":"957_CR197","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1161\/ATVBAHA.112.245381","volume":"32","author":"W Martinet","year":"2012","unstructured":"Martinet, W. et al. Everolimus triggers cytokine release by macrophages: rationale for stents eluting everolimus and a glucocorticoid. Arterioscler. Thromb. Vasc. Biol. 32, 1228\u20131235 (2012).","journal-title":"Arterioscler. Thromb. Vasc. Biol."}],"container-title":["Nature Reviews Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41569-023-00957-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41569-023-00957-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41569-023-00957-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,18]],"date-time":"2024-04-18T09:02:01Z","timestamp":1713430921000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41569-023-00957-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,2]]},"references-count":197,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["957"],"URL":"https:\/\/doi.org\/10.1038\/s41569-023-00957-0","relation":{},"ISSN":["1759-5002","1759-5010"],"issn-type":[{"value":"1759-5002","type":"print"},{"value":"1759-5010","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,2]]},"assertion":[{"value":"2 November 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}